We aspire to be a dynamic R&D organization by focusing on the best science for those therapies that can deliver true innovation for patients. We will build deep disease area expertise in our core therapeutic areas, strengthen our pipeline and create an inspiring culture.
We are committed to bringing Better Health and a Brighter Future to patients by translating science into highly-innovative medicines. We focus on our R&D efforts on four therapeutic areas: Oncology, Gastroenterology (GI), Neuroscience and Rare Disease. We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines.